APA (7th ed.) Citation

RT, P., A, A., A, O., K, S., DR, K., & NH, L. (2025). Increased insulin resistance following switch from efavirenz to cobicistat-boosted elvitegravir. Antiviral therapy, 30(1), 13596535251314571. https://doi.org/10.1177/13596535251314571

Chicago Style (17th ed.) Citation

RT, Pickering, Asundi A, Olson A, Soden K, Kuritzkes DR, and Lin NH. "Increased Insulin Resistance Following Switch from Efavirenz to Cobicistat-boosted Elvitegravir." Antiviral Therapy 30, no. 1 (2025): 13596535251314571. https://doi.org/10.1177/13596535251314571.

MLA (9th ed.) Citation

RT, Pickering, et al. "Increased Insulin Resistance Following Switch from Efavirenz to Cobicistat-boosted Elvitegravir." Antiviral Therapy, vol. 30, no. 1, 2025, p. 13596535251314571, https://doi.org/10.1177/13596535251314571.